1,036 results on '"Parker, Peter J."'
Search Results
2. Drug-resistant EGFR mutations promote lung cancer by stabilizing interfaces in ligand-free kinase-active EGFR oligomers
3. Chemical Genetic Identification of PKC Epsilon Substrates in Mouse Brain.
4. Control of atypical PKCι membrane dissociation by tyrosine phosphorylation within a PB1-C1 interdomain interface
5. Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts
6. A cancer-associated, genome protective programme engaging PKCε
7. Equivocal, explicit and emergent actions of PKC isoforms in cancer
8. Quantification of biomarker functionality predicts patient outcomes
9. A genetically-encoded crosslinker screen identifies SERBP1 as a PKCε substrate influencing translation and cell division
10. Into the fold: advances in understanding aPKC membrane dynamics
11. Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications
12. 222-G Beyond PD-L1: unraveling the enigma of immunotherapy response in PD-L1 negative (<1%) NSCLC patients through quantification of PD-1/PD-L1 engagement in the tumor microenvironment
13. Protein Kinase C: Structural Definition
14. Protein Kinase C-β Dictates B Cell Fate by Regulating Mitochondrial Remodeling, Metabolic Reprogramming, and Heme Biosynthesis
15. Michael D. Waterfield
16. Integrin-Specific Signaling Pathways Controlling Focal Adhesion Formation and Cell Migration
17. Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma
18. Author Correction: The Aurora B specificity switch is required to protect from non-disjunction at the metaphase/anaphase transition
19. The Aurora B specificity switch is required to protect from non-disjunction at the metaphase/anaphase transition
20. A New Era of Personalized Medicine
21. Imaging Protein Kinase Cα Activation in Cells
22. Protein kinase N1 critically regulates cerebellar development and long-term function
23. Protein Kinase C Isotypes Controlled by Phosphoinositide 3-Kinase Through the Protein Kinase PDK1
24. The T766M-EGFR lung cancer mutation promotes tumor growth by exploiting newfound mechanisms assembling ligand-free EGFR oligomer structures
25. Data from PKCϵ Controls Mitotic Progression by Regulating Centrosome Migration and Mitotic Spindle Assembly
26. Figure S2 from PKCϵ Controls Mitotic Progression by Regulating Centrosome Migration and Mitotic Spindle Assembly
27. Supplementary Figures Legend from PKCϵ Controls Mitotic Progression by Regulating Centrosome Migration and Mitotic Spindle Assembly
28. Induction and Phosphorylation of Protein Kinase C-α and Mitogen-Activated Protein Kinase by Hypoxia and by Radiation in Chinese Hamster V79 Cells
29. aPKC Inhibition by Par3 CR3 Flanking Regions Controls Substrate Access and Underpins Apical-Junctional Polarization
30. Supplementary FRET Methods from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
31. Supplementary Figure from Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells
32. Supplementary Figures and Tables from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
33. Supplementary Table from Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells
34. Data from Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells
35. Data Supplement from Chromosomal Instability Selects Gene Copy-Number Variants Encoding Core Regulators of Proliferation in ER+ Breast Cancer
36. Data from High-Throughput Time-Resolved FRET Reveals Akt/PKB Activation as a Poor Prognostic Marker in Breast Cancer
37. Data from Chromosomal Instability Selects Gene Copy-Number Variants Encoding Core Regulators of Proliferation in ER+ Breast Cancer
38. Data Supplement from High-Throughput Time-Resolved FRET Reveals Akt/PKB Activation as a Poor Prognostic Marker in Breast Cancer
39. Data from The PKC/NF-κB Signaling Pathway Induces APOBEC3B Expression in Multiple Human Cancers
40. Supplementary Figures S1 through S6 and Supplementary Tables S1 and S2 from The PKC/NF-κB Signaling Pathway Induces APOBEC3B Expression in Multiple Human Cancers
41. Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer
42. Control of atypical PKCι membrane dissociation by tyrosine phosphorylation within a PB1-C1 interdomain interface
43. Effect of Phosphorylation on EGFR Dimer Stability Probed by Single-Molecule Dynamics and FRET/FLIM
44. Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury
45. Control of MT1-MMP transport by atypical PKC during breast-cancer progression
46. The architecture of EGFR’s basal complexes reveals autoinhibition mechanisms in dimers and oligomers
47. PKN2 deficiency leads both to prenatal ‘congenital’ cardiomyopathy and defective angiotensin II stress responses
48. Localised interventions in cellular processes
49. 14-3-3 Proteins Interact with a Hybrid Prenyl-Phosphorylation Motif to Inhibit G Proteins
50. PKN2 deficiency leads both to prenatal ‘congenital’ cardiomyopathy and defective angiotensin II stress responses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.